Lung remodeling in pulmonary tuberculosis

被引:186
作者
Dheda, K
Booth, H
Huggett, JF
Johnson, MA
Zumla, A
Rook, GAW
机构
[1] UCL Royal Free & Univ Coll Med Sch, Middlesex Hosp, Dept Thorac Med, London W1T 4JF, England
[2] UCL Royal Free Hosp, Ctr Infect Dis & Int Hlth, London NW3 2QG, England
[3] UCL Royal Free Hosp, Dept Thorac & HIV Med, London NW3 2QG, England
关键词
D O I
10.1086/444545
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tuberculosis is a global public health catastrophe responsible for 18 million cases of illness and 2 million deaths annually. Pulmonary cavitation with cough-generated aerosol is the principle means of spread, and lung remodeling (healed cavitation, fibrosis, and bronchiectasis) is a major cause of lung disability, surpassing all other diffuse parenchymal lung diseases combined. Efficient granuloma turnover is mycobactericidal, and extracellular matrix is disbanded without scarring. In many with progressive disease, however, there is dysregulated granuloma turnover, liquefactive necrosis, and pathological scarring. The pathological mechanisms and the related immunological pathways underpinning these phenomena are reviewed in the present article. Further studies are needed to identify and develop specific immunotherapeutic interventions that target immunopathology, since they have the potential to substantially reduce spread.
引用
收藏
页码:1201 / 1210
页数:10
相关论文
共 162 条
[71]   ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(P2X(7)) receptors [J].
Lammas, DA ;
Stober, C ;
Harvey, CJ ;
Kendrick, N ;
Panchalingam, S ;
Kumararatne, DS .
IMMUNITY, 1997, 7 (03) :433-444
[72]   Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro [J].
Laochumroonvorapong, P ;
Paul, S ;
Manca, C ;
Freedman, VH ;
Kaplan, G .
INFECTION AND IMMUNITY, 1997, 65 (11) :4850-4857
[73]  
Lawrence CE, 1998, EUR J IMMUNOL, V28, P2672, DOI 10.1002/(SICI)1521-4141(199809)28:09&lt
[74]  
2672::AID-IMMU2672&gt
[75]  
3.0.CO
[76]  
2-F
[77]   Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1 [J].
Lee, CG ;
Homer, R ;
Zhou, Z ;
Lanone, Z ;
Wang, XM ;
Koteliansky, V ;
Shipley, JM ;
Gotwals, P ;
Noble, P ;
Chen, QS ;
Senior, RM ;
Elias, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (06) :809-821
[78]   IMMUNOHISTOCHEMICAL LOCALIZATION OF TRANSFORMING GROWTH FACTOR-BETA(1) IN THE NONNECROTIZING GRANULOMAS OF PULMONARY SARCOIDOSIS [J].
LIMPER, AH ;
COLBY, TV ;
SANDERS, MS ;
ASAKURA, S ;
ROCHE, PC ;
DEREMEE, RA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (01) :197-204
[79]   Transforming growth factor-β1 overexpression in tumor necrosis factor-α receptor knockout mice induces fibroproliferative lung disease [J].
Liu, JY ;
Sime, PJ ;
Wu, TJ ;
Warshamana, GS ;
Pociask, D ;
Tsai, SY ;
Brody, AR .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (01) :3-7
[80]   VENTILATION AND TRANSFER OF GASES IN PULMONARY TUBERCULOSIS [J].
LOPEZMAJ.V .
RESPIRATION, 1973, 30 (01) :48-63